By FieldPulse Editorial · February 4, 2026
Tags: sales-force, glp-1, hiring
Eli Lilly is adding 800 sales reps to its tirzepatide field organization, one of the largest single-year pharma expansions in recent memory.
Eli Lilly confirmed in a Q1 2026 investor briefing that it is adding approximately 800 field representatives across its Mounjaro and Zepbound commercial organizations, representing one of the largest single-year sales force expansions in the company's history. The expansion is driven by persistent demand that has outpaced detailing capacity in primary care and endocrinology call points. Lilly cited research showing that rep-visited accounts are converting at 2.4x the rate of undetailed accounts, even in markets where awareness of tirzepatide is high. The build includes new primary care territo